Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

TVTXTVTX

Showing 8 of 21 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in TRAVERE THERAPEUTICS INC

Current Value

$338,304

Current Shares

5,955

Total Value Change

-$195,331

Total Shares Change

-32,189

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5,955
-82.2%
$338,3040.0%$56.81
0
2026-Q1
Decreased
33,361
-46.4%
$991,1550.0%$28.27
0
2025-Q4
Decreased
62,186
-35.0%
$2.4M0.0%$37.68
0
2025-Q3
Decreased
95,747
-52.5%
$2.3M0.0%$24.04
0
2025-Q2
Increased
201,508
+23.3%
$3M0.0%$14.77
32
2025-Q1
Increased
163,378
+278.1%
$2.9M0.0%$19.68
42
2024-Q4
Increased
43,213
+13.3%
$752,7700.0%$17.32
28
2024-Q3
Increased
38,144
+2.3%
$533,6350.0%$14.01
25

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used